Mobile app version of munafa.us
Login or Join
 Learn then Earn
stockMarketNEWS

 story : CinCor Pharma raised 4 million as upsized IPO prices in middle of expected range #FinanceUSA #StockMarketNEWS CinCor Pharma Inc. is set to go public on the Nasdaq Friday, after the Massachusetts-based

@stockMarketNEWS Sun 09 Jan, 2022

Posted in: #FinanceUSA #StockMarketNEWS

CinCor Pharma raised 4 million as upsized IPO prices in middle of expected range #FinanceUSA #StockMarketNEWS
CinCor Pharma Inc. is set to go public on the Nasdaq Friday, after the Massachusetts-based biopharmaceutical company's upsized initial public offering priced overnight at a share, in the middle of the expected range of between and a share. The company raised 3.6 million as it sold 12.1 million shares in the IPO, up from previous expectations of an 11.0 million share offering. The IPO pricing values the company at about 6.7 million. Morgan Stanley, Jefferies and Evercore ISI are the joint book-running managers of the IPO, and Oppenheimer is the lead manager. The company is going public at a time of relative investor disdain for IPOs, as the Renaissance IPO ETF has tumbled 19.2% over the past three months while the S&P 500 has gained 6.7%.


Munafa USA Munafa India Munafa NSE


Report

Login to follow story

More posts by @stockMarketNEWS

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

Daily analysis, news, Munafa stocks list in email:

Back to top | Use Dark Theme